Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
XEBRA BRANDS Aktie jetzt für 0€ handeln | |||||
00:54 | Xebra Brands Ltd (2): Xebra Brands details plans for 2025 | 1 | Stockwatch | ||
Di | Xebra Brands Ltd: Xebra Brands Unveils Strategic 2025 Roadmap to Accelerate Growth in North American CBD Market | 594 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / February 25, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0) is pleased to announce the development of the Strategic 2025 Roadmap... ► Artikel lesen | |
13.02. | Xebra Brands Ltd (2): Xebra Brands closes $448,146 shares for debt deal | 2 | Stockwatch | ||
13.02. | Xebra Brands Ltd: Xebra Brands Announces Closing of Shares for Debt Transaction | 203 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESS... ► Artikel lesen | |
22.01. | Xebra Brands plans non-brokered private placement and concurrent debt settlement | 2 | Seeking Alpha | ||
22.01. | Xebra Brands Ltd (2): Xebra arranges private placement, debt settlement | 8 | Stockwatch | ||
22.01. | Xebra Brands Ltd: Xebra Brands Announces Non-Brokered Private Placement and Concurrent Debt Settlement | 326 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESS... ► Artikel lesen | |
11.12.24 | Xebra Brands Ltd (2): Xebra Brands to extend 13.31 million warrants to June | 3 | Stockwatch | ||
11.12.24 | Xebra Brands Ltd: Xebra Brands Announces Warrant Extension | 255 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / December 11, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a cannabis company, is pleased to announce that, subject to the approval... ► Artikel lesen | |
07.11.24 | Xebra Brands Ltd (2): Xebra enters Mexican distribution deal for Elements | 11 | Stockwatch | ||
07.11.24 | Xebra Brands Ltd: Xebra Brands Executes First Distribution Agreement | 168 | ACCESS Newswire | ICAN Pharmacies to list ELEMENT Branded Products VANCOUVER, BC / ACCESSWIRE / November 7, 2024 / Xebra Brands ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading player in the Mexican... ► Artikel lesen | |
12.09.24 | Xebra Brands Ltd (2): Xebra extends expiry date of 13.31M warrants to Dec. 31 | 4 | Stockwatch | ||
12.09.24 | Xebra Brands Ltd: Xebra Brands Announces Warrant Extension | 317 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / September 12, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a cannabis company, is pleased to announce the extension of the expiry... ► Artikel lesen | |
19.07.24 | Xebra Brands Ltd: Xebra Brands Announces Closing of Shares for Debt Transaction | 352 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESSWIRE... ► Artikel lesen | |
17.07.24 | Xebra Brands Ltd: Xebra Brands Engages Industry Leading CPG Executive to Lead Expansion into Mexico and US | 400 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / July 17, 2024 / Xebra Brands, a leader in the cannabis industry, is pleased to announce the engagement of MPC Co, a prominent consulting group in the cannabis space, led... ► Artikel lesen | |
26.06.24 | Xebra Brands Ltd: Xebra Brands Announces Strategic Update on Partnerships, Growth Opportunities, and Commercial Expansion | 355 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / June 26, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a developing cannabis company and the only company legally allowed to cultivate... ► Artikel lesen | |
10.06.24 | Xebra Brands Ltd: Xebra Brands Executes First Ever Purchase Order of CBD Products | 310 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / June 10, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), XEBRA, an evolving player in the cannabis industry, is proud to announce... ► Artikel lesen | |
04.06.24 | Xebra Brands Ltd: Xebra Brands Congratulates President Elect Claudia Sheinbaum on Historic Victory as Mexico's First Woman President | 390 | ACCESS Newswire | XEBRA Brands Inc Applauds President-Elect Claudia Sheinbaum's Stance on Cannabis Reform and Looks Forward to Collaboration for Industry Growth VANCOUVER, BC / ACCESSWIRE / June 4, 2024 / Xebra Brands... ► Artikel lesen | |
16.04.24 | Xebra Brands Ltd: Xebra Brands Receives Second CBD Product Approval by COFEPRIS | 305 | ACCESS Newswire | Xebra Expands Elements Brand of CBD products for Mexican Consumers VANCOUVER, BC / ACCESSWIRE / April 16, 2024 / Xebra Brands Ltd. (CSE:XBRA)(OTCQB:XBRAD)(FSE:9YC0) ("Xebra" or the "Company"), a leading... ► Artikel lesen | |
04.04.24 | Xebra Brands Ltd: Xebra Brands Submits Third Product Submission to COFEPRIS, Expanding Elements Brand CBD Lineup | 492 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / April 4, 2024 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading company in the CBD and cannabis industry, is proud to announce... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 22,850 | +0,93 % | Evotec oder Bayer: Wo gelingt der Ausbruch? | Mit Evotec und Bayer kämpfen zwei populäre deutsche Kleinanleger-Titel derzeit um einen charttechnischen Ausbruch. Beide Werte besitzen das Potenzial, in den kommenden Wochen aus ihrer länger etablierten... ► Artikel lesen | |
AURORA CANNABIS | 5,240 | +3,05 % | Aurora Cannabis Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
CANOPY GROWTH | 1,448 | +1,12 % | Canopy Growth: Buffett steigt (indirekt) ein | Aus den jüngsten 13F-Berichten geht hervor, dass Warren Buffett beim größten Wein-Produzenten der Welt, Constellation Brands, eingestiegen ist. Damit geht Buffett auch ein - höchstwahrscheinlich ungewolltes... ► Artikel lesen | |
TILRAY BRANDS | 0,784 | +2,03 % | Tilray Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
INNOCAN PHARMA | 0,145 | +4,69 % | Aktie im Fokus: Patentierung löst Rallye aus… | ||
CRONOS GROUP | 1,784 | -1,05 % | Cronos Group Inc: Cronos Group to hold 2024 conference call Feb. 27 | ||
SYNBIOTIC | 3,800 | +0,26 % | SYNBIOTIC plant weitere Übernahmen in 2025 | Mitteilung der SYNBIOTIC SE: SYNBIOTIC mit vier neuen Beteiligungen in 2024: Weitere Übernahmen für 2025 in Sicht Die europäische Industriehanf- und Cannabis-Unternehmensgruppe SYNBIOTIC SE (ISIN DE000A3E5A59... ► Artikel lesen | |
NEKTAR THERAPEUTICS | 0,850 | +2,41 % | Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata | SAN FRANCISCO, Feb. 26, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AA... ► Artikel lesen | |
ORAMED PHARMACEUTICALS | 2,040 | 0,00 % | Oramed Aktie: Besorgniserregende Signale? | Die Oramed Pharmaceuticals Aktie verzeichnete am 22. Februar 2025 einen signifikanten Rückgang. Der Aktienkurs fiel um 3,15 Prozent auf 2,15 USD, was einem Minus von 0,07 USD gegenüber dem vorherigen... ► Artikel lesen | |
OPKO HEALTH | 1,560 | -0,28 % | OPKO Health, Inc.: ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program | Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executedDevelopment... ► Artikel lesen | |
JAGUAR HEALTH | 0,720 | +1,94 % | Jaguar Health, Inc.: Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure | This study, initiated yesterday, is one of five clinical efforts - three proof-of-concept (POC) investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,096 | +2,43 % | SELLAS Life Sciences Group, Inc.: SELLAS Announces Positive Data from Phase 2a Trial of SLS009 in Combination with Zanubrutinib in DLBCL | - Combination Achieved a 67% of Overall Response Rate, More than Double that of Zanubrutinib Alone; 83% Disease Control Rate in Difficult-to-Treat Non-GCB DLBCL (ABC DLBCL) Patients - - Median Overall... ► Artikel lesen | |
XORTX THERAPEUTICS | 0,804 | -0,74 % | XORTX initiiert Gichtprogramm und NDA-Gespräche mit der FDA | - Typ-C-Meeting ist Voraussetzung für
die Einleitung eines verkürzten NDA-Zulassungsverfahrens für XRx-026 zur Gichtbehandlung
CALGARY, AB - 24. Februar 2025 / IRW-Press... ► Artikel lesen | |
NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness announces CFO transition | ||
TALPHERA | 0,543 | +7,10 % | Talphera, Inc.: Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study | Submission of a Prior Approval Supplement for a reduction in the number of patients in the NEPHRO CRRT study is expected within the coming week
The FDA agreed to... ► Artikel lesen |